Ophthotech closes $30 million in funding to support phase 2 trial of AMD treatment.Published in:Ocular Surgery News, 2010, v. 28, n. 2, p. 38Publication type:Article
Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration.Published in:Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 487, doi. 10.1038/nrd4375By:Cully, MeganPublication type:Article